Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

FinScreener

EUR/USD

1.1994

0.0037

0.31%

GBP/USD

1.3510

-0.0002

-0.02%

USD/JPY

111.59

0.1035

0.09%

USD/CHF

0.9625

0.0008

0.08%

EUR/GBP

0.8878

0.0029

0.33%

USD/CAD

1.2292

0.0013

0.10%

NZD/USD

0.7315

0.0057

0.78%

EUR/JPY

133.85

0.5430

0.41%

EUR/CHF

1.1544

0.0046

0.40%

AC Immune Sa

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
10.92-0.28-2.50%Vol 98 8091Y Perf -30.27%
Sep 19th, 2017 16:00
BID10.92 ASK11.04
Open11.15 Previous Close11.20
Pre-Market- After-Trading-
 - -%  - -%
Target Price
23.00 
Analyst Rating
Strong Buy 1.00
Potencial %
110.62 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)622 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
35.08 
Earnings Date
8th Nov 2017

Today's Price Range

10.8211.70

 

52wk Range

6.0319.97

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Month
45.83%
3 Months
31.61%
6 Months
-7.21%
1 Year
-30.27%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
ACIU10.92-0.2800-2.50
AAPL158.730.06000.04
GOOG921.816.81000.74
MSFT75.440.28000.37
XOM80.220.13000.16
WFC53.360.65001.23
JNJ135.22-0.1600-0.12
FB172.522.51001.48
GE24.20-0.2600-1.06
JPM93.941.02001.10
...

TickerPriceChg.%52 Week High
LUK24.293.9427.33
KORS46.183.4352.67
NRG24.623.2726.25
AA46.202.8746.44
PGR47.632.8549.01
MGM32.562.7834.65
ALB134.652.77135.26
NTAP41.712.6645.24
DE123.082.66132.50
VZ49.342.6054.83
FCX14.482.4817.06
WYNN147.012.20147.50
T38.212.1143.03
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 21.10
Current Ratio 21.60
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -4.30
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-523.30
EBITDA Margin-516.40
Pre-tax Profit Margin-
Profit Margin-42.10
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.95
PS Ratios 137.48
Price to Cash Flow 35.80
Price to Free Cash Flow -28.90
Cash Flow Per Share -0.35
Price to Tangible Book4.93
Book Value per Share2.21
Enterprise Value (in ths.)493 013
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -33.58
Return on Assets (5Y Avg) -
ROA last 12 Months -30.26
Return on Capital (5Y Avg) -
ROC last 12 Months -31.43
Return on invested Capital Q -6.50
Return on invested Capital Y-9.80
Assets Turnover0.10
Receivables Turnover6.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)4 526
Revenue per Share 0.08
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.19-280.00Negative
12/2017 QR-0.1052.38Positive
12/2017 FY-0.64-20.75Negative
12/2018 FY-0.75-10.29Negative
Next Report Date8th Nov 2017
Estimated EPS Next Report-0.19
Estimates Count2
EPS Growth Next 5 Years %0.00
Volume Overview
Volume98 809
Shares Outstanding (in ths.)56 920
Trades Count258
Dollar Volume865 676
Avg. Volume48 115
Avg. Weekly Volume111 529
Avg. Monthly Volume113 892
Avg. Quarterly Volume54 610

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

63%38%

Bearish Bullish

86%14%

Bearish Bullish

92%8%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x